Scarica l'app Stockscreener
80.94
1.84%
-1.52
Dopo l'orario di chiusura:
79.00
-1.94
-2.40%
Precedente Chiudi:
$82.46
Aprire:
$82.64
Volume 24 ore:
1.21M
Relative Volume:
0.72
Capitalizzazione di mercato:
$14.02B
Reddito:
$8.28B
Utile/perdita netta:
$1.43B
Rapporto P/E:
9.914
EPS:
8.1642
Flusso di cassa netto:
$-203.00M
1 W Prestazione:
+3.29%
1M Prestazione:
+10.30%
6M Prestazione:
-1.17%
1 anno Prestazione:
+7.13%
Intervallo 1D:
$80.66
$82.72
Intervallo di 1 settimana:
$77.87
$83.42
Portata 52W:
$62.38
$88.20
Solventum Corp Stock (SOLV) Company Profile
Nome
Solventum Corp
Settore
Industria
Telefono
651-733-1110
Indirizzo
1750 YANKEE DOODLE ROAD, EAGAN
Compare SOLV vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
80.94 | 14.28B | 8.28B | 1.43B | -203.00M | 8.1642 |
ISRG
Intuitive Surgical Inc
|
412.02 | 151.09B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.79 | 41.89B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
66.11 | 33.11B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.54 | 30.45B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
193.57 | 28.57B | 5.54B | 1.52B | 1.74B | 10.37 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-24 | Iniziato | Rothschild & Co Redburn | Sell |
| 2026-01-26 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2026-01-20 | Aggiornamento | Mizuho | Neutral → Outperform |
| 2025-12-02 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2025-10-01 | Iniziato | UBS | Neutral |
| 2025-09-11 | Iniziato | Jefferies | Hold |
| 2025-07-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | Aggiornamento | Argus | Hold → Buy |
| 2025-06-06 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-10-08 | Iniziato | Stifel | Buy |
| 2024-10-07 | Iniziato | Piper Sandler | Neutral |
| 2024-09-26 | Iniziato | Wolfe Research | Peer Perform |
| 2024-09-05 | Iniziato | BTIG Research | Neutral |
| 2024-06-24 | Iniziato | Argus | Hold |
| 2024-05-30 | Iniziato | Goldman | Sell |
| 2024-05-10 | Iniziato | BofA Securities | Neutral |
| 2024-04-10 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Iniziato | Wells Fargo | Equal Weight |
| 2024-04-02 | Iniziato | Edward Jones | Hold |
Mostra tutto
Solventum Corp Borsa (SOLV) Ultime notizie
Daily Brief Health Care: Laurus Labs, Ascendis Pharma, GSK , Incyte Corp, Insmed Inc, Johnson & Johnson, Kardigan, LogicMark, Parabilis Medicines, Solventum and more - Smartkarma
The future of clear aligners: how Clarity Aligners from Solventum can improve treatment precision - Digital Journal
Solventum Corp. stock rises Tuesday, outperforms market - MarketWatch
3M Company stock (US88579Y1010): Spin-off hangover and legal risks keep investors on edge - AD HOC NEWS
3M Company stock (US88579Y1010): Board shake-up and post-spin future after Solventum deal - AD HOC NEWS
Why Solventum Stock Is Sinking Despite Strong Earnings - TipRanks
Solventum trends for 2026: AI coding, tariffs, and margins - MSN
Solventum Corp. stock falls Monday, underperforms market - MarketWatch
3M Company stock (US88579Y1010): Spin-off of Solventum reshapes the conglomerate - AD HOC NEWS
Solventum Trends for 2026: AI Coding, Tariffs, and Margins - Zacks Investment Research
Q1 Earnings Roundup: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & ConsumablesDiversified Segment - StockStory
Is Solventum’s (SOLV) Governance Tweaks Hinting At How It Will Navigate AI Disruption? - Yahoo Finance
Assessing Solventum (SOLV) Valuation As AI Disruption Fears Challenge Health Information Systems Prospects - simplywall.st
AI Models Turn More Constructive on Solventum (SOLV) as Profitability and Valuation Stand Out - TipRanks
Solventum (SOLV) Q1 2026 Earnings Transcript - AOL.com
Solventum Corporation 8-K Filing: Company Details, Address, Ticker, and Exchange Information (June 2, 2026) - Minichart
Solventum (SOLV) Q1 2026 Earnings Call Transcript - Fortune
Why Solventum (SOLV) Is Up 8.1% After Q1 Beat And $1 Billion Buyback Announcement - Sahm
Solventum Corp. stock rises Thursday, outperforms market - MSN
Solventum Resolves Bylaw Litigation and Case Closed - TipRanks
Solventum Corp. stock outperforms market despite losses on the day - MarketWatch
Solventum (NYSE: SOLV) closes By-law challenge with $120K mootness fee payment - Stock Titan
Solventum executive pay disclosure includes $11M severance for ex-MedSurg leader - Medical Design & Outsourcing
Solventum Corporation (SOLV) Fell as Its HCIT Unit Hurt by AI Disruption Fears - Yahoo Finance
Executives at Solventum commute to Minnesota by plane. A shareholder wants to change that - MSN
Solventum Corp. stock rises Wednesday, outperforms market - MarketWatch
SOLV Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Solventum Corp. stock rises Monday, outperforms market - MarketWatch
Solventum Corporation (SOLV) Stock Analysis: Strong Return on Equity and Investor Ratings Signal Potential Growth - DirectorsTalk Interviews
3M Company stock (US88579Y1010): technical picture in focus after Solventum spin-off and PFAS headli - AD HOC NEWS
3M Company stock (US88579Y1010): shares react to recent spin-off of Solventum and technical picture - AD HOC NEWS
Solventum (SOLV) recently broke out above the 200-day moving average - MSN
Solventum Corp. stock falls Friday, underperforms market - MarketWatch
Trian Presses Solventum Over Private‑Jet Exec Commutes - Hoodline
Minnesota’s Solventum to pay $1.6M fine for selling equipment to Chinese firms - MSN
Executives at this Minnesota company commute here by plane. A shareholder wants to change that. - Star Tribune
Solventum (SOLV) Q4 2025 Earnings Call Transcript - Fortune
Solventum Adopts Updated Executive Severance and Compensation Plan - The Globe and Mail
Solventum Corporation 8-K Filing: Executive Severance Plan, Key Company Information & NYSE Listing (2026) - Minichart
Executive severance revised at Solventum (NYSE: SOLV) with new pay and benefits - Stock Titan
Solventum to Participate in the 2026 Jefferies Healthcare Conference - PR Newswire
Goldman Sachs Adjusts Price Target on Solventum to $67 From $66, Maintains Sell Rating - marketscreener.com
Jefferies healthcare conference to feature Solventum live chat - Stock Titan
3M Company stock (US88579Y1010): Spin-off of Solventum reshapes the industrial giant - AD HOC NEWS
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), BillionToOne, Inc. Class A (BLLN) and Solventum Corporation (SOLV) - The Globe and Mail
Solventum Beats Consensus Estimates for 1Q26 - Medical Device and Diagnostic industry
Solventum Corporation (SOLV) Stock Report: Is A 6.83% Upside Worth The Dive? - DirectorsTalk Interviews
3M Company stock (US88579Y1010): spin-off, earnings pressure and legal risks in focus - AD HOC NEWS
Assessing Solventum (SOLV) Valuation As Recent Momentum Meets Perceived Undervaluation - simplywall.st
Solventum stock is recovering: What's going on? - MSN
3M Company stock (US88579Y1010): Q1 2026 earnings and Solventum spin-off reshape the industrial gian - AD HOC NEWS
Solventum Corp Azioni (SOLV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.36%
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):